Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $608.0800 (0.76%) ($601.8890 - $611.5600) on Tue. Jun. 9, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.67% (three month average) | RSI | 63 | Latest Price | $608.0800(0.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.3% a day on average for past five trading days. | Weekly Trend | REGN advances 3.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(56%) XLV(45%) SPLV(39%) IVW(37%) IWF(36%) | Factors Impacting REGN price | REGN will decline at least -1.835% in a week (0% probabilities). VIXM(-20%) VXX(-7%) UUP(-6%) TBT(-5%) IYT(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.835% (StdDev 3.67%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $602.27(0.96%) | 10 Day Moving Average | $596.73(1.9%) | 20 Day Moving Average | $581.55(4.56%) | To recent high | -1.7% | To recent low | 41.9% | Market Cap | $64.474b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |